Gene set enrichment analysis of data from Lechman et al., revealed that the LSC-enriched fraction (CD34+/CD38−) in AML 8227 is enriched for MYC target genes expression as compared to non-LSCs (CD34−) (Fig. 6c) [44]. This evidence concerns the gene MYC and acute myeloid leukemia.